Hidden mutations in Cornelia de Lange syndrome limitations of sanger sequencing in molecular diagnostics

Diana Braunholz, Carolin Obieglo, Ilaria Parenti, Jelena Pozojevic, Juliane Eckhold, Benedikt Reiz, Ingrid Brænne, Kerstin S. Wendt, Erwan Watrin, Julia Vodopiutz, Harald Rieder, Gabriele Gillessen-Kaesbach, Frank J. Kaiser*

*Corresponding author for this work
9 Citations (Scopus)


Cornelia de Lange syndrome (CdLS) is a well-characterized developmental disorder. The genetic cause of CdLS is a mutation in one of five associated genes (NIPBL, SMC1A, SMC3, RAD21, and HDAC8) accounting for about 70% of cases. To improve our current molecular diagnostic and to analyze some of CdLS candidate genes, we developed and established a gene panel approach. Because recent data indicate a high frequency of mosaic NIPBL mutations that were not detected by conventional sequencing approaches of blood DNA, we started to collect buccal mucosa (BM) samples of our patients that were negative for mutations in the known CdLS genes. Here, we report the identification of three mosaic NIPBL mutations by our high-coverage gene panel sequencing approach that were undetected by classical Sanger sequencing analysis of BM DNA. All mutations were confirmed by the use of highly sensitive SNaPshot fragment analysis using DNA from BM, urine, and fibroblast samples. In blood samples, we could not detect the respective mutation. Finally, in fibroblast samples from all three patients, Sanger sequencing could identify all the mutations. Thus, our study highlights the need for highly sensitive technologies in molecular diagnostic of CdLS to improve genetic diagnosis and counseling of patients and their families.

Original languageEnglish
JournalHuman Mutation
Issue number1
Pages (from-to)26-29
Number of pages4
Publication statusPublished - 01.01.2015


Dive into the research topics of 'Hidden mutations in Cornelia de Lange syndrome limitations of sanger sequencing in molecular diagnostics'. Together they form a unique fingerprint.

Cite this